Literature DB >> 11136240

Novel therapies in the search for a cure for Huntington's disease.

M F Beal1, P Hantraye.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11136240      PMCID: PMC33346          DOI: 10.1073/pnas.98.1.3

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  25 in total

1.  The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription.

Authors:  J S Steffan; A Kazantsev; O Spasic-Boskovic; M Greenwald; Y Z Zhu; H Gohler; E E Wanker; G P Bates; D E Housman; L M Thompson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

2.  Polyglutamine expansion down-regulates specific neuronal genes before pathologic changes in SCA1.

Authors:  X Lin; B Antalffy; D Kang; H T Orr; H Y Zoghbi
Journal:  Nat Neurosci       Date:  2000-02       Impact factor: 24.884

3.  Transplanted fetal striatum in Huntington's disease: phenotypic development and lack of pathology.

Authors:  T B Freeman; F Cicchetti; R A Hauser; T W Deacon; X J Li; S M Hersch; G M Nauert; P R Sanberg; J H Kordower; S Saporta; O Isacson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

4.  Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient.

Authors:  P Piccini; D J Brooks; A Björklund; R N Gunn; P M Grasby; O Rimoldi; P Brundin; P Hagell; S Rehncrona; H Widner; O Lindvall
Journal:  Nat Neurosci       Date:  1999-12       Impact factor: 24.884

5.  CREB-binding protein sequestration by expanded polyglutamine.

Authors:  A McCampbell; J P Taylor; A A Taye; J Robitschek; M Li; J Walcott; D Merry; Y Chai; H Paulson; G Sobue; K H Fischbeck
Journal:  Hum Mol Genet       Date:  2000-09-01       Impact factor: 6.150

6.  Motor and cognitive improvements in patients with Huntington's disease after neural transplantation.

Authors:  A C Bachoud-Lévi; P Rémy; J P Nguyen; P Brugières; J P Lefaucheur; C Bourdet; S Baudic; V Gaura; P Maison; B Haddad; M F Boissé; T Grandmougin; R Jény; P Bartolomeo; G Dalla Barba; J D Degos; F Lisovoski; A M Ergis; E Pailhous; P Cesaro; P Hantraye; M Peschanski
Journal:  Lancet       Date:  2000-12-09       Impact factor: 79.321

7.  Neuroprotective effects of creatine in a transgenic mouse model of Huntington's disease.

Authors:  R J Ferrante; O A Andreassen; B G Jenkins; A Dedeoglu; S Kuemmerle; J K Kubilus; R Kaddurah-Daouk; S M Hersch; M F Beal
Journal:  J Neurosci       Date:  2000-06-15       Impact factor: 6.167

8.  Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease.

Authors:  M Chen; V O Ona; M Li; R J Ferrante; K B Fink; S Zhu; J Bian; L Guo; L A Farrell; S M Hersch; W Hobbs; J P Vonsattel; J H Cha; R M Friedlander
Journal:  Nat Med       Date:  2000-07       Impact factor: 53.440

9.  Fetal striatal allografts reverse cognitive deficits in a primate model of Huntington disease.

Authors:  S Palfi; F Condé; D Riche; E Brouillet; C Dautry; V Mittoux; A Chibois; M Peschanski; P Hantraye
Journal:  Nat Med       Date:  1998-08       Impact factor: 53.440

10.  Functional neuronal replacement by grafted striatal neurones in the ibotenic acid-lesioned rat striatum.

Authors:  O Isacson; P Brundin; P A Kelly; F H Gage; A Björklund
Journal:  Nature       Date:  1984 Oct 4-10       Impact factor: 49.962

View more
  1 in total

1.  Polymeric Nanovehicle Regulated Spatiotemporal Real-Time Imaging of the Differentiation Dynamics of Transplanted Neural Stem Cells after Traumatic Brain Injury.

Authors:  Zhe Wang; Yu Wang; Zhiyong Wang; Jun Zhao; J Silvio Gutkind; Avinash Srivatsan; Guofeng Zhang; Hsien-Shun Liao; Xiao Fu; Albert Jin; Xiao Tong; Gang Niu; Xiaoyuan Chen
Journal:  ACS Nano       Date:  2015-06-02       Impact factor: 15.881

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.